Saturday, November 7, 2026
22.9 C
Bengaluru

The Semaglutide Story: How One Molecule Re‑wired Obesity, Patents and Pharma Profits

1. From Gut Hormone to “Wonder Drug”

If you strip away the hype, semaglutide is simply a clever copy of a natural hormone that tells the body “you’ve eaten enough.”[1]
In the 1980s and 1990s, researchers discovered that the gut hormone GLP‑1 could lower blood sugar, slow digestion and curb appetite, but the natural hormone disappeared from the body within minutes.[2][3]

So Novo Nordisk chemists spent years “armouring” GLP‑1—tweaking its structure so it survived longer in the bloodstream and could be given as a weekly injection instead of a constant drip.[4][5]
One of those tweaked versions was semaglutide, designed to stay active for around a week, which made it practical for real‑world use in diabetes and, later, obesity.[6][7]

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Closing the Value Gap in Indian Pharma: What Doctors Really Want from Digital Engagement

Indian pharma is investing heavily in digital engagement. But...

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Topics

Indian Pharma 2026: The Growth Engine Is Changing

The Indian Pharmaceutical Market isn't just growing. Its centre...

Anand Shetty Appointed CEO – Emerging Markets at Cadila Pharmaceuticals

Cadila Pharmaceuticals has appointed Anand Shetty as Chief Executive...

The paradox of the “Pharmacy of the World.” 💊

India has world-scale formulation capability, yet the chemistry beneath...

The Innovator’s Gene and the Generic’s Promise

A medicine must first be discovered. It must then...

Private Equity in Indian Healthcare: Who Is Investing Beyond the Metros?

Private capital is transforming India's healthcare landscape. But is...
spot_img

Related Articles

spot_imgspot_img